Personalized Prediction of Hospital Mortality in COVID-19-Positive Patients

Daniel Rozenbaum1, Jacob Shreve1, Nathan Radakovich2

  • 1Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.

Insights

Researchers developed a machine learning model to predict in-hospital mortality and length of stay for patients with coronavirus disease 2019 (COVID-19). This tool aids healthcare systems in resource allocation for COVID-19 patients.

Area of Science:

  • * Medical Informatics
  • * Machine Learning in Healthcare
  • * Public Health

Background:

  • * Coronavirus disease 2019 (COVID-19) poses a significant challenge to healthcare systems globally.
  • * Accurate prediction of patient outcomes is crucial for effective resource management.

Purpose of the Study:

  • * To develop and validate predictive models for in-hospital mortality.
  • * To predict length of stay (LOS) for hospitalized COVID-19 patients.
  • * To create a decision tool for healthcare systems.

Main Methods:

  • * Multicenter retrospective cohort study of 764 COVID-19-positive patients.
  • * Utilized LightGBM, a machine learning algorithm, for prediction.
  • * Models were developed to predict mortality at 7, 14, and 30 days, and in-hospital LOS.

Main Results:

  • * The model achieved an area under the receiver operating characteristics curve of 0.86 for 7-day, 0.88 for 14-day, and 0.85 for 30-day mortality.
  • * Identified key predictors including age, initial ICU admission, race, and organ dysfunction.
  • * Median LOS was 5 days for the general floor and 10 days for the ICU.

Conclusions:

  • * A validated decision tool for predicting COVID-19 patient mortality and LOS was developed.
  • * The tool provides explainable and patient-specific predictions.
  • * Aids healthcare systems in optimizing bed allocation and resource distribution.
Abstract

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
902
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
493
Prediction Intervals01:03

Prediction Intervals

The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.5K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
346
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
174